Strongly worded editorial:"Biotech Daily EditorialThe failure of...

Strongly worded editorial:

"Biotech Daily Editorial
The failure of Biota’s board and management to capitalize on a $US231 million contract is
a breath-taking debacle.
The claims by the company that it would acquire $US54 million at a better rate than
otherwise available, by merging with Nabi, proved false and it settled for $US27 million.
The claim by the company that it would be more effective closer to the funding and
regulatory authorities was proved false when it relocated 500 miles away in Georgia.
The claims by the company that it had no idea why BARDA issued a stop-work order and
terminated the contract, were refuted by BARDA director Dr Robin Robinson.
The closure of the Australian operation undertaking the fundamental research that brought
the world Relenza and the ongoing programs is a disgrace.
The board and senior management should resign and repay their salaries to shareholders."
Biotech Daily editor David Langsam holds Biota shares
Biotech Daily